Your search history is turned on.
Date: February 29, 2024 Jurisdictions: British Columbia, Ontario
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Michelle Lee, Chief Financial Officer of Moss Genomics Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Moss Genomics Inc. (the issuer) for the interim pe...
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Karl Cahill, Chief Executive Officer of Moss Genomics Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Moss Genomics Inc. (the issuer) for the interim...
1 MOSS GENOMICS INC. Management Discussion and Analysis For the three and six months ended December 31, 2023 and 2022 (Expressed in Canadian Dollars) Moss Genomics Inc. Management Discussion and Analysis For...
Microsoft Word - Moss Genomics Inc. - FS - Q2 December 31 2023 - FINAL.docx Moss Genomics Inc. Condensed Consolidated Interim Financial Statements For the three and six months ended December 31, 2023 and 2022 Expressed in Canadian Dollars - Unaudited NOTICE OF NO AUDITOR ...
Date: November 29, 2023 Jurisdictions: British Columbia, Ontario
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Michelle Lee, Chief Financial Officer of Moss Genomics Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Moss Genomics Inc. (the issuer) for the interi...
1 MOSS GENOMICS INC. Management Discussion and Analysis For the three months ended September 30, 2023 and 2022 (Expressed in Canadian Dollars) Moss Genomics Inc. Management Discussion and Analysis For the th...
Moss Genomics Inc. Condensed Consolidated Interim Financial Statements For the three months ended September 30, 2023 and 2022 Expressed in Canadian Dollars - Unaudited NOTICE OF NO AUDITOR REVIEW OF INTERIM FI...
Date: October 30, 2023 Jurisdictions: British Columbia, Ontario
FORM 52-109FV2 FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Michelle Lee, in my capacity, as Chief Financial Officer of Moss Genomics Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements, and annual MD&A, including, for greater certainty, all documents and informatio...
FORM 52-109FV2 FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Karl Cahill, in my capacity, as Chief Executive Officer of Moss Genomics Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements, and annual MD&A, including, for greater certainty, all documents and information...